- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-29-0018095

Genderma Pharmaceuticals Private Limited
About Genderma Pharmaceuticals Private Limited
Data last updated:
Genderma Pharmaceuticals Private Limited is a private limited company based in Shahjahanpur, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 02 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2020PTC133757. Its GSTIN is 09AAICG4980G1Z9 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mithlesh Kumari Rajput and Anit Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shahjahanpur, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹63.13 Lakh, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹14,434 (net margin 0.2%) and EBITDA of ₹3.12 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years.
As per MCA filings, the company has open charges of ₹15.71 Lakh and satisfied charges of ₹10 Lakh on record.
Genderma Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0018095).
Company details
Recognitions & Rankings of Genderma Pharmaceuticals
Contact details
Genderma Pharmaceuticals Private Limited's registered office is in Shahjahanpur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Mithlesh Kumari Rajput, Chinour Near.Sunita Brick Field, Shahjahanpur, Uttar Pradesh, India – 242001
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Genderma Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Genderma Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Genderma Pharmaceuticals Private Limited, buy the company report.
Financials of Genderma Pharmaceuticals Private Limited
FY 2025 filings availableGenderma Pharmaceuticals Private Limited reported revenue of ₹63.13 Lakh (down 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 26% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 49%. EBITDA rose 104% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14,434 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genderma Pharmaceuticals Private Limited, buy the company report.
Board of directors of Genderma Pharmaceuticals Private Limited
Genderma Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mithlesh Kumari Rajput | Director | 02 Sep 2020 | 6 Years 2 Months | Current |
| Anit Kumar | Additional Director | 20 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Genderma Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Driven Pharmaceuticals Private Limited | ₹63.45 Lakh (FY 2024) | 48.0% | Lucknow, Uttar Pradesh, India | |||
| Kiaora Pharmaceuticals Private Limited | ₹63.35 Lakh (FY 2025) | -22.0% | Jalandhar, Punjab, India | |||
| Genderma Pharmaceuticals Private Limitedthis company | ₹63.13 Lakh (FY 2025) | ₹14,434 | 0.2% | -26.0% | Shahjahanpur, Uttar Pradesh, India | |
| Susruta Pharmaceuticals Private Limited | ₹63.09 Lakh (FY 2022) | -26.0% | Kolkata, West Bengal, India | |||
| Acer Pharmaceuticals Private Limited | ₹62.91 Lakh (FY 2025) | 32.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Genderma Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Oct 2025 | 101178267 | State Bank of India | ₹15.71 Lakh | Open | |
| 14 Oct 2024 | 101004639 | Canara Bank | ₹10 Lakh | Satisfied |
To see the full charge records of Genderma Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Genderma Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genderma Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Genderma Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICG4980G1Z9 | Uttar Pradesh | Active | 26 Oct 2020 |
To see the full GST registrations and return filing status of Genderma Pharmaceuticals Private Limited, buy the company report.
Recent activity
Genderma Pharmaceuticals Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Anit Kumar was appointed as Additional Director on 20 Apr 2023.
Frequently asked questions
Genderma Pharmaceuticals is an active private limited company based in Shahjahanpur, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 02 September 2020 (6+ years old) and is registered under CIN U51909UP2020PTC133757.
Genderma Pharmaceuticals has 2 current directors:
- Mithlesh Kumari Rajput - Director
- Anit Kumar - Additional Director
The latest financial statements of Genderma Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Genderma Pharmaceuticals is 09AAICG4980G1Z9, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Genderma Pharmaceuticals is U51909UP2020PTC133757. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genderma Pharmaceuticals was incorporated on 02 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Genderma Pharmaceuticals by revenue are Driven Pharmaceuticals Private Limited, Kiaora Pharmaceuticals Private Limited, Susruta Pharmaceuticals Private Limited, Acer Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anit Kumar was appointed as Additional Director on 20 Apr 2023. Manoj Kumar Dwivedi ceased to be Director on 20 Apr 2023. Aman Prit Singh ceased to be Director on 04 Oct 2022. Genderma Pharmaceuticals has 4 board changes on record in total.
Yes, Genderma Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-29-0018095).
The registered office of Genderma Pharmaceuticals is at CO Mithlesh Kumari Rajput, Chinour Near.Sunita Brick Field, Shahjahanpur, Uttar Pradesh, India – 242001.
Genderma Pharmaceuticals operates in the trading industry, in the specialty segment.

